Purchase Order 75N91019P00441

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $14,200 on May 24, 2019, with completion by August 1, 2019. The order is firm fixed price with no set-aside designation. Metabolon will deliver a relative concentration profile of small-molecule entities (endogenous compounds, xenobiotics, and metabolites) extracted from 40 cell pellets and detected via the HD4 global metabolomics platform, provided as an Excel file. The awardee will supply an outline of analytical...

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $16,000 on June 25, 2018, with final completion on June 24, 2019. The order is firm fixed price with no set-aside. Work is performed in Morrisville, North Carolina. Metabolon, a self-certified small disadvantaged business, provides metabolomics analysis services, including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry across biological...

<p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $55,450 on July 1, 2020, for metabolome analysis of human fresh-frozen breast samples, xenograft tissues, and cell pellets associated with breast cancer metabolism in the context of diabetes and stress. Performance takes place in Morrisville, North Carolina, and the order completes September 30, 2020. The awardee is a self-certified small disadvantaged business. No set-aside was used.</p>

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $19,200.00 on August 1, 2018, with final completion on August 18, 2018. No set-aside was used. Work is performed in Morrisville, North Carolina. The order covers metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.

The National Cancer Institute awarded a $12,000 firm fixed-price purchase order to Metabolon, Inc. on June 8, 2018, with final completion on June 7, 2019. Performance is at Metabolon's facility in Morrisville, North Carolina. The order procures metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at forty-seven thousand two hundred forty-two dollars and six cents ($47,242.06) to Metabolon, Inc. to measure metabolomic and lipidomic concentrations on fifty-eight incident pancreatic cancer cases and fifty-eight controls, along with six blinded replicate quality control samples, totaling one hundred twenty-two...

<p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $14,400.00 on September 15, 2017. No set-aside was used. The order is firm fixed price and runs through November 1, 2017. Work is performed in Morrisville, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomics services, including metabolomic profiling of biological samples using advanced analytical techniques to support federal research initiatives.</p>

The National Cancer Institute awarded a $16,000 purchase order to Metabolon, Inc. for custom metabolomics services on July 25, 2017, with completion on July 25, 2018. Work is performed in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Metabolon is a self-certified small disadvantaged business specializing in metabolomic profiling and analysis using advanced chromatography and mass spectrometry techniques across biological sample types including plasma,...

The National Cancer Institute awarded a $16,200 purchase order to Metabolon, Inc. for lab and testing services, effective November 26, 2019 with completion by January 31, 2020. Work is performed in Morrisville, North Carolina. No set-aside category applies. Metabolon, a self-certified small disadvantaged business, provides metabolomics services including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry for biological...

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for laboratory testing services on July 27, 2017, with a ceiling value of $15,500.00 and a completion date of July 31, 2018. Work is performed in Durham, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomic analysis and profiling services using advanced analytical techniques including ultra-high performance liquid chromatography and tandem mass spectrometry. The purchase order...